From: Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia
 | Male (n = 98) | Female (n = 78) | ||||
---|---|---|---|---|---|---|
Cognition impairment group (n = 49) | Cognition normal group (n = 49) | P value | Cognition impairment group (n = 39) | Cognition normal group (n = 39) | P value | |
Age (years) | 38.43 ± 11.90 | 37.10 ± 11.57 | 0.513 | 35.79 ± 11.10 | 33.90 ± 10.97 | 0.415 |
BMI (kg/m2) | 24.55 ± 3.96 | 24.76 ± 3.92 | 0.989 | 24.44 ± 3.23 | 24.72 ± 4.34 | 0.845 |
Education (years) | 12.16 ± 3.23 | 12.76 ± 3.06 | 0.568 | 13.15 ± 3.65 | 13.21 ± 2.60 | 0.848 |
Hypertension (yes/no) | 0/49 | 0/49 | 1 | 3/36 | 2/37 | 1 |
Diabetes mellitus (yes/no) | 2/47 | 3/46 | 1 | 0/39 | 0/39 | 1 |
Total disease duration (months) | 171.14 ± 110.28 | 157.12 ± 135.05 | 0.325 | 138.76 ± 135.27 | 122.20 ± 111.92 | 0.905 |
Total PANSS score | 61.35 ± 20.11 | 61.00 ± 19.45 | 0.904 | 62.21 ± 17.77 | 55.31 ± 16.32 | 0.049* |
TBIL (μmol/L) | 11.05 ± 5.01 | 14.98 ± 8.75 | 0.03* | 11.87 ± 4.72 | 9.96 ± 6.04 | 0.015* |
TC (mmol/L) | 4.47 ± 0.98 | 4.59 ± 0.81 | 0.134 | 4.57 ± 0.89 | 4.68 ± 1.36 | 0.916 |
TG (mmol/L) | 1.80 ± 1.80 | 1.74 ± 1.11 | 0.654 | 1.52 ± 0.88 | 2.08 ± 5.14 | 0.325 |
LDL (mmol/L) | 2.80 ± 0.81 | 2.98 ± 0.84 | 0.134 | 2.83 ± 1.65 | 2.58 ± 0.75 | 0.853 |
HDL (mmol/L) | 1.09 ± 0.29 | 1.29 ± 1.33 | 0.601 | 1.38 ± 0.46 | 1.36 ± 0.27 | 0.503 |
Mean chlorpromazine equivalent (mg) | 542.84 ± 350.92 | 578.97 ± 314.36 | 0.611 | 644.79 ± 320.76 | 614.42 ± 308.44 | 0.671 |